METASTATIC NSCLC
Clinical trials for METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New biosimilar drug tested against established cancer treatment
Disease control TerminatedThis study aims to see if a new, potentially more affordable version of the cancer drug pembrolizumab (called GME751) works as well and is as safe as the original drug. It will involve 218 adults with untreated metastatic non-small cell lung cancer. Participants will receive eith…
Matched conditions: METASTATIC NSCLC
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Apr 04, 2026 05:51 UTC
-
Nanoparticle 'Booster' trial aims to supercharge cancer treatment
Disease control OngoingThis early-stage trial is testing whether injecting a nanoparticle called NBTXR3 directly into a tumor, then activating it with radiation, can make immunotherapy work better for people with advanced cancers. The study will enroll about 145 patients with various cancers that have …
Matched conditions: METASTATIC NSCLC
Phase: PHASE1 • Sponsor: Nanobiotix • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Blood test could predict who benefits from cancer immunotherapy
Knowledge-focused OngoingThis study aims to find a better way to predict which patients with advanced lung or head and neck cancer will respond to immunotherapy. Researchers will collect blood samples from 75 participants before and during their standard immunotherapy treatment. They will measure how qui…
Matched conditions: METASTATIC NSCLC
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC